Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved sector : Health technology save search
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
MRK | $125.8 0.46% 3.4M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
health treatment for canada advanced keytruda
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | $13.455 4.38% 1.6M
|
n/a
|
| O: 4.19%
H: 0.0%
C: 0.0%
KMDA | $5.21 2.16% 26K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
humira biosimilar approved for agreement
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.19 0.23% 740K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
entyvio fda disease active for therapy
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $25.95 5.53% 10K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | News | $25.95 5.53% 10K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
biopharma platform
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
Published: 2024-04-17 (Crawled : 09:00) - globenewswire.com
BCRX | $4.31 -4.22% 2.7M
|
Health Technology
|
| O: 2.97%
H: 0.0%
C: 0.0%
orladeyo health approval
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.1612 -8.98% 27M
|
Health Technology
|
| O: 26.26%
H: 73.2%
C: 18.87%
health cancer care for commercial
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | News | $25.95 5.53% 10K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
biopharma platform
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.31 0.28% 7.4K
|
Health Technology
|
| O: 0.19%
H: 0.28%
C: 0.0%
approval for meeting
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
XOMA | News | $25.95 5.53% 10K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
biopharma platform
Illumina's planned divestment of GRAIL approved by the European Commission
Published: 2024-04-12 (Crawled : 13:00) - prnewswire.com
ILMN | $117.07 0.33% 740K
|
Health Technology
|
| O: -1.3%
H: 4.53%
C: -1.5%
approved
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | $138.24 800
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | $68.41 0.07% 2.9M
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.3 -1.52% 4.3M
|
Health Technology
|
| O: 2.92%
H: 3.41%
C: 2.27%
ocu400 approval positive for therapy
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
VVOS | $2.66 24K
|
Health Technology
|
| O: -0.33%
H: 13.91%
C: -8.77%
approval care for medical
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $30.49 1.84% 350K
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.56 -5.07% 1.2M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 approved preclinical for therapeutics
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
fda approval for hiv living
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
VERO | $0.85 1.19% 13K
|
Health Technology
|
| O: 1.51%
H: 0.0%
C: -9.59%
approval for max
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.